MedPage Today on MSN
Novel Rapid-Acting Drug Proves Effective in Severe PTSD
Results support the neuroplastogen as a "potential acute, intermittent" therapy, researche ...
Germany: A recent phase 3 randomized, placebo-controlled trial published in Nature Medicine in September 2025 reports that a ...
Collins initially took to X to defend the rule, calling criticism “fake news” and stating the policy “simply formalizes VA’s ...
The Department of Veterans Affairs (VA) this week abruptly reversed course on a new rule requiring veterans’ disability ratings to be calculated by how well they function on medication and not on the ...
VA is proposing major changes to disability ratings for sleep apnea, tinnitus, and mental health, shifting away from device based formulas and toward functional impairment.
USA: The investigational neuroplastogen TSND-201 demonstrated significant efficacy in patients with severe post-traumatic stress disorder (PTSD) in a randomized phase II trial. A ...
Shareholder/Analyst Call February 17, 2026 7:30 PM ESTCompany ParticipantsPatrick Redmond O'SullivanEdward Chung - CEO, ...
President Donald Trump’s net approval rating reached a record low of -12 in Morning Consult’s weekly survey, while the share of respondents who said his administration is focused on cost-of-living ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results